129 related articles for article (PubMed ID: 12855144)
1. [After the ALLHAT trial, what do we know about treatment for hypertension that we did not know before?].
González-Juanatey JR
Rev Esp Cardiol; 2003 Jul; 56(7):642-8. PubMed ID: 12855144
[No Abstract] [Full Text] [Related]
2. A family physician questions the conclusions from ALLHAT.
Standridge JB
Am J Hypertens; 2004 Apr; 17(4):361-5. PubMed ID: 15062891
[TBL] [Abstract][Full Text] [Related]
3. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.
Berecek KH; Farag A; Bahtiyar G; Rothman J; McFarlane SI
Curr Hypertens Rep; 2004 Jun; 6(3):212-4. PubMed ID: 15128474
[No Abstract] [Full Text] [Related]
4. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
Beevers DG; Lee KW; Lip GY
J Hum Hypertens; 2003 Jun; 17(6):367-72. PubMed ID: 12764397
[No Abstract] [Full Text] [Related]
5. LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?
Nicholls MG
J Hum Hypertens; 2004 May; 18(5):295-300. PubMed ID: 14739907
[No Abstract] [Full Text] [Related]
6. ALLHAT: a saga of missed opportunities.
McInnes GT
J Hum Hypertens; 2003 Jun; 17(6):373-7. PubMed ID: 12764398
[No Abstract] [Full Text] [Related]
7. The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort.
Hebert LA; Rovin BH; Hebert CJ
Nat Clin Pract Nephrol; 2007 Feb; 3(2):60-1. PubMed ID: 17251990
[No Abstract] [Full Text] [Related]
8. ALLHAT in perspective: implications to clinical practice and clinical trials.
Yusoff K
Med J Malaysia; 2005 Jun; 60(2):239-45. PubMed ID: 16114170
[TBL] [Abstract][Full Text] [Related]
9. A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue.
Cardinal H; Monfared AA; Dorais M; LeLorier J
Can J Cardiol; 2004 Mar; 20(4):417-21. PubMed ID: 15057318
[TBL] [Abstract][Full Text] [Related]
10. ALLHAT: definitive answers or continuing uncertainty?
Sever P;
J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):3-5. PubMed ID: 12692746
[No Abstract] [Full Text] [Related]
11. Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization.
Xie F; Petitti DB; Chen W
Am J Hypertens; 2005 Apr; 18(4 Pt 1):464-9. PubMed ID: 15831354
[TBL] [Abstract][Full Text] [Related]
12. [ALLHAT--remaining questions await answers].
Nilsson PM
Lakartidningen; 2004 Jan; 101(3):220, 223; discussion 224-7. PubMed ID: 14763096
[No Abstract] [Full Text] [Related]
13. ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial.
Elliott WJ
Am J Hypertens; 1996 Apr; 9(4 Pt 1):409-11. PubMed ID: 8722446
[No Abstract] [Full Text] [Related]
14. [What did the ALLHAT study bring? To do the one without foregoing the other].
MMW Fortschr Med; 2003 Dec; 145(51-52):36-7. PubMed ID: 14974327
[No Abstract] [Full Text] [Related]
15. Letter by barrios et Al regarding article, "heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial".
Barrios V; Escobar C; Echarri R
Circulation; 2009 Aug; 120(5):e31; author reply e32. PubMed ID: 19652116
[No Abstract] [Full Text] [Related]
16. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
[TBL] [Abstract][Full Text] [Related]
17. Trials and tribulations.
Packard CJ
Int J Clin Pract Suppl; 2002 Oct; (132):3-10. PubMed ID: 12425357
[No Abstract] [Full Text] [Related]
18. Letter by Ben-Dov and Bursztyn regarding article, "Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial".
Ben-Dov IZ; Bursztyn M
Circulation; 2007 Jan; 115(2):e18; author reply e19. PubMed ID: 17228008
[No Abstract] [Full Text] [Related]
19. ALLHAT: what has it taught us so far?
Leenen FH
CMAJ; 2004 Sep; 171(7):719-20. PubMed ID: 15451829
[No Abstract] [Full Text] [Related]
20. ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
Onuigbo MA
Arch Intern Med; 2009 Oct; 169(19):1810; author reply 1810-1. PubMed ID: 19858442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
